HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ai-Young Lee Selected Research

Vitiligo

11/2023Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm.
11/2023Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force-Part 2: Specific treatment recommendations.
6/2021The long-term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo.
1/2021Development of evidence-based consensus on critical issues in the management of patients with vitiligo: A modified Delphi study.
12/2017Reduced Nrf2 activation in PI3K phosphorylation-impaired vitiliginous keratinocytes increases susceptibility to ROS-generating chemical-induced apoptosis.
2/2014Patch test reactions in patients with the additional diagnosis of vitiligo.
4/2013The therapeutic effects of a topical tretinoin and corticosteroid combination for vitiligo: a placebo-controlled, paired-comparison, left-right study.
12/2010Histamine effect on melanocyte proliferation and vitiliginous keratinocyte survival.
9/2010Reduced aquaporin3 expression and survival of keratinocytes in the depigmented epidermis of vitiligo.
12/2009Association of thymic stromal lymphopoietin gene -847C>T polymorphism in generalized vitiligo.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ai-Young Lee Research Topics

Disease

12Vitiligo
11/2023 - 12/2004
9Melanosis (Freckles)
11/2023 - 02/2010
7Atopic Dermatitis (Atopic Eczema)
08/2020 - 03/2012
5Hyperpigmentation
11/2023 - 11/2012
5Melanoma (Melanoma, Malignant)
09/2022 - 02/2013
4Allergic Contact Dermatitis
07/2016 - 05/2004
4Dermatitis
01/2016 - 02/2013
3Skin Diseases (Skin Disease)
08/2020 - 02/2013
3Hypersensitivity (Allergy)
07/2016 - 12/2005
2Cicatrix (Scar)
05/2024 - 03/2011
2Neoplasms (Cancer)
09/2022 - 01/2021
2Skin Neoplasms (Skin Cancer)
06/2021 - 01/2021
2Psoriasis (Pustulosis Palmaris et Plantaris)
08/2020 - 06/2015
2Contact Dermatitis (Eczema, Contact)
07/2016 - 08/2012
2Autoimmune Diseases (Autoimmune Disease)
06/2015 - 01/2011
2Drug Eruptions (Drug Eruption)
09/2013 - 03/2003
2Atrophy
04/2013 - 12/2004
2Drug-Related Side Effects and Adverse Reactions
05/2004 - 03/2003
1Thyroid Neoplasms (Thyroid Cancer)
05/2024
1Retinitis Pigmentosa (Pigmentary Retinopathy)
12/2023
1Glioma (Gliomas)
11/2023
1Parakeratosis
05/2023
1Acne Vulgaris
04/2023
1Hypoxia (Hypoxemia)
09/2022
1Neoplasm Metastasis (Metastasis)
09/2022
1Seborrheic Keratosis
11/2021
1Lymphoma (Lymphomas)
06/2021
1Ichthyosis (Xeroderma)
08/2020
1Keratosis
04/2020
1Alopecia (Baldness)
01/2019
1Lichen Planus (Lichen Ruber Planus)
01/2019
1Phototoxic Dermatitis (Phototoxicity)
05/2017
1Genetic Predisposition to Disease (Genetic Predisposition)
11/2015
1Burns
06/2014
1Wounds and Injuries (Trauma)
06/2014
1Warts (Wart)
11/2013

Drug/Important Bio-Agent (IBA)

5CytokinesIBA
06/2015 - 11/2007
4Glucosamine (Dona)IBA
06/2015 - 02/2013
4Cyclosporine (Ciclosporin)FDA LinkGeneric
06/2015 - 02/2013
3Guanine DeaminaseIBA
01/2023 - 04/2020
3Hair DyesIBA
07/2016 - 07/2004
3AllergensIBA
03/2015 - 12/2005
2Melanins (Melanin)IBA
11/2023 - 01/2014
2CollagenIBA
05/2023 - 03/2011
2Isotretinoin (Accutane)FDA LinkGeneric
04/2023 - 01/2019
2Uric Acid (Urate)IBA
01/2023 - 11/2021
2MicroRNAs (MicroRNA)IBA
08/2020 - 11/2015
2Coloring Agents (Dyes)IBA
07/2016 - 07/2004
2Tuberculin (PPD)IBA
07/2016 - 07/2004
24-phenylenediamine (p-phenylenediamine)FDA Link
07/2016 - 07/2004
2osteoblast cadherinIBA
06/2016 - 12/2014
2Proteins (Proteins, Gene)FDA Link
01/2015 - 11/2012
2Immunoglobulin E (IgE)IBA
11/2013 - 02/2013
2Adrenal Cortex Hormones (Corticosteroids)IBA
04/2013 - 12/2004
2Tretinoin (Retinoic Acid)FDA LinkGeneric
04/2013 - 12/2004
2Therapeutic UsesIBA
04/2013 - 03/2013
2Interleukin-4 (Interleukin 4)IBA
02/2013 - 02/2013
2Interleukin-6 (Interleukin 6)IBA
02/2013 - 11/2007
2Estrogens (Estrogen)FDA Link
11/2012 - 02/2010
1GTP Phosphohydrolases (GTPases)IBA
12/2023
1Heme Oxygenase-1IBA
11/2023
1NF-E2-Related Factor 2IBA
11/2023
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2023
1IDF-11774IBA
09/2022
1Cyclin D1IBA
09/2022
1Calcineurin InhibitorsIBA
06/2021
1Dihydrolipoamide Dehydrogenase (Lipoamide Dehydrogenase)IBA
01/2021
1NAD (NADH)IBA
01/2021
1Complement System Proteins (Complement)IBA
01/2021
1Succinic Acid (Succinate)IBA
01/2021
1GuanineIBA
04/2020
1RetinoidsIBA
01/2019
1AcitretinFDA Link
01/2019
1AlitretinoinFDA Link
01/2019
1AntibodiesIBA
12/2017
1hydroquinone (Esoterica)FDA Link
12/2017
1dihydroethidiumIBA
12/2017
1butylphenIBA
12/2017
1Cystatin AIBA
05/2017
1ElafinIBA
05/2017
1Caspase 3 (Caspase-3)IBA
05/2017
1ferrous sulfateFDA Link
07/2016
1Ethanolamine (Colamine)IBA
07/2016
1Fibronectins (Fibronectin)IBA
01/2016
1Gonadal Steroid Hormones (Sex Hormones)IBA
11/2015
1Imiquimod (Aldara)FDA LinkGeneric
06/2015
1Cadherins (E-Cadherin)IBA
12/2014
1Skin Lightening PreparationsIBA
11/2014
1Disinfectants (Biocides)IBA
06/2014
1Untranslated RNA (Noncoding RNA)IBA
04/2014
1AntigensIBA
02/2014
1diphenylcyclopropenoneIBA
11/2013
1ChemokinesIBA
11/2013
1Tacrolimus (Prograf)FDA LinkGeneric
11/2013

Therapy/Procedure

8Therapeutics
11/2023 - 03/2011
3Phototherapy (Light Therapy)
06/2021 - 11/2013
1Thyroidectomy
05/2024
1Aftercare (After-Treatment)
09/2022
1Drug Therapy (Chemotherapy)
01/2021
1Immunotherapy
11/2013